Parkinson Disease: all 4,583 studies
Page 46 of 46. Open to participants first (1,097), then studies with results posted, then the rest; newest registration first within each.
- A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's DiseaseCompletedNCT00139867Phase 3
- Biomechanical Parameters of Gait in Patients With Parkinson's Disease and Parkinsonian SyndromesTerminatedNCT00139321Not applicable
- Parkin Mutations and Their Functional ConsequencesCompletedNCT00136721
- A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/LevodopaCompletedNCT00134966Phase 3
- Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's DiseaseCompletedNCT00134251Phase 3
- Study of Brain Imaging With Nuclear Technology in Individuals With Parkinsonian SyndromeCompletedNCT00132626Phase 2
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's DiseaseCompletedNCT00129181Not applicable
- Stalevo in Early Wearing-Off PatientsCompletedNCT00125567Phase 4
- Efficacy of Voice Treatment for Parkinson's DiseaseCompletedNCT00123084Not applicable
- Stress-Busting Program for Caregivers of Patients With Neruological DiseasesCompletedNCT00122174Not applicable
- A Study of Neurophysiologic Changes in Individuals With Parkinson's DiseaseCompletedNCT00117195
- Study of Liatermin (r-metHuGDNF) Administered by Bilateral Intraputaminal (IPu) Infusion to Subjects With Idiopathic Parkinson's DiseaseCompletedNCT00115427Phase 1
- Trial of Extended Treatment With Liatermin (r-metHuGDNF) Administered by Continuous Intraputaminal (IPu)Infusion to Subjects With Idiopathic Parkinson's Disease Who Have Completed a Previous Trial of LiaterminCompletedNCT00111982Phase 1/2
- Talampanel to Treat Parkinson's DiseaseCompletedNCT00108667Phase 2
- Genetic Characterization of Parkinson's DiseaseCompletedNCT00105131
- Consortium On Risk for Early-onset Parkinson's Disease (CORE PD)CompletedNCT00104585
- Efficacy of Therapeutic Interventions for Orthostatic Hypotension in Parkinson's Disease and Multiple System AtrophyCompletedNCT00103597Phase 1
- Incidence of Parkinson's Disease Among VeteransCompletedNCT00100438
- A Study of the Sense of Smell in Relatives of Parkinson's Disease PatientsCompletedNCT00096876
- Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's DiseaseCompletedNCT00096720Phase 2
- Aripiprazole in Patients With Psychosis Associated With Parkinson's DiseaseCompletedNCT00095810Phase 4
- Relationship of Dopamine to Cognitive Function in Parkinson's DiseaseCompletedNCT00094601
- Lisuride Patch to Treat Parkinson's DiseaseCompletedNCT00089622Phase 2
- Biological Markers in Parkinson's DiseaseCompletedNCT00088335
- Treatment of Hallucinosis/Psychosis in Parkinson's Disease by an Investigational DrugCompletedNCT00087542Phase 2
- ACP-103 to Treat Parkinson's DiseaseCompletedNCT00086294Phase 2
- Parkinson's Research: The Organized Genetics InitiativeCompletedNCT00086073
- Levetiracetam Treatment of L-dopa Induced DyskinesiasCompletedNCT00076674Phase 2
- Cell Studies of Parkinson's DiseaseCompletedNCT00076505
- NINDS Parkinson's Disease Neuroprotection Trial of CoQ10 and GPI 1485CompletedNCT00076492Phase 2
- Valerian to Improve Sleep in Patients With Parkinson's DiseaseCompletedNCT00070928Phase 2
- Studying Automatic Movements in Patients With Parkinson's DiseaseCompletedNCT00063661
- Investigating the Safety of srTMS in the Treatment of Parkinson's DiseaseCompletedNCT00063284Phase 1
- National Institute of Neurological Disorders and Stroke (NINDS) Parkinson's Disease Neuroprotection TrialCompletedNCT00063193Phase 2
- Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's DiseaseCompletedNCT00058838Phase 3
- Single Photon Emission Computed Tomography to Study Receptors in Parkinson's DiseaseCompletedNCT00058721
- Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter)CompletedNCT00056524Phase 3
- Deep Brain Stimulation for Parkinson's Disease TrialCompletedNCT00053625Phase 3
- Parkinson's Diseases Susceptibility Genes and PesticidesCompletedNCT00044590
- Treatment of Agitation/Psychosis in Dementia/Parkinsonism (TAP/DAP)CompletedNCT00043849Phase 4
- Catechol Thioethers in Parkinson's DiseaseCompletedNCT00042692
- Farming and Movement Evaluation Study (FAME)CompletedNCT00042120
- Molecular Epidemiology of Parkinson's DiseaseCompletedNCT00042107
- Safety and Efficacy Study of CEP-1347 in the Treatment of Parkinson's DiseaseTerminatedNCT00040404Phase 2/3
- JP-1730 to Treat Parkinson's DiseaseCompletedNCT00040209Phase 2
- How the Loss of Dopamine and Dopamine-Restoring Medicines Affect Movement PerformanceCompletedNCT00040196
- Embryonic Dopamine Cell Implants for Parkinson's DiseaseCompletedNCT00038116Phase 3
- Effects of Talampanel on Patients With Advanced Parkinson's DiseaseCompletedNCT00036296Phase 1/2
- Study Evaluating Sumanirole for the Treatment of the Signs and Symptoms of Early Parkinson's Disease.CompletedNCT00036218Phase 3
- Open Label Sumanirole Study of Safety, Tolerability, and Therapeutic Response In Patients With Parkinson's DiseaseTerminatedNCT00036205Phase 3
- The Role of Dopamine in Motor Learning in Healthy Subjects and Patients With Parkinson's DiseaseCompletedNCT00032812
- Donepezil to Treat Dementia in Parkinson's DiseaseCompletedNCT00030979Phase 4
- Chinese Exercise Modalities in Parkinson's DiseaseCompletedNCT00029809Phase 1/2
- Study of Repetitive Transcranial Magnetic Stimulation in Parkinson's DiseaseCompletedNCT00029666Phase 2
- Magnetic Stimulation for Parkinson DiseaseCompletedNCT00029276Phase 1
- Effect of Stimulus Rate on Cognitive and Motor Activity in Young Subjects, Elderly Subjects, and Patients With Parkinson's DiseaseCompletedNCT00026598
- PET Scanning in Parkinson s DiseaseCompletedNCT00024622
- Transcranial Magnetic Stimulation in Parkinson's DiseaseCompletedNCT00023062
- The Association of Neurotoxin Exposure With Parkinson's Disease and Parkinsonism in World War II Veterans and Other MenCompletedNCT00018577
- Riluzole to Treat Parkinson's DiseaseCompletedNCT00013624Phase 2
- EMD 128130 for the Treatment of Parkinson's DiseaseCompletedNCT00009048Phase 2
- Continuously Infused Intracerebral (IC) Recombinant-Methionyl Human Glial Cell Line-Derived Neurotrophic Factor (r-metHuGDNF) for the Treatment of Idiopathic Parkinson's DiseaseCompletedNCT00006488Phase 1
- KW-6002 to Treat Parkinson's DiseaseCompletedNCT00006337Phase 2
- Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's DiseaseCompletedNCT00006077Phase 2
- Randomized Study of Fetal Neurotransplantation for the Treatment of Parkinson's DiseaseStatus unknownNCT00004844Not applicable
- Study of Clozapine for the Treatment of Psychosis in Patients With Idiopathic Parkinson's DiseaseCompletedNCT00004826Not applicable
- Study of Axial Mobility Exercises in Parkinson DiseaseCompletedNCT00004760Not applicable
- Timing of Levodopa Treatment in Parkinson's DiseaseCompletedNCT00004733Phase 3
- Parkinson's Disease Treatment With Coenzyme Q10CompletedNCT00004731Phase 2
- Phase II Study of Pallidotomy for Parkinson DiseaseCompletedNCT00004670Phase 2
- Study of LY300164 for the Treatment of Parkinson's DiseaseCompletedNCT00004576Phase 2
- Randomized Study of the Effects of Glucose on Cognition in Healthy Young and Elderly People and Parkinson's Disease PatientsCompletedNCT00004451Not applicable
- Phase II Double Blind Controlled Trial of Nigral Grafting in Patients With Parkinson's DiseaseCompletedNCT00004387Phase 2
- Treatment of Parkinson's Disease With a Transdermal Skin PatchCompletedNCT00001931Phase 2
- Treatment of Parkinson's Disease With EliprodilCompletedNCT00001929Phase 2
- Intravenous Levodopa for the Diagnosis of Parkinson's DiseaseCompletedNCT00001928
- Effects of Brain Stimulation on Learning and ReasoningCompletedNCT00001776
- Transcranial Magnetic Stimulation for the Treatment of Parkinson's DiseaseCompletedNCT00001665
- Gene Analysis of Parkinson's DiseaseCompletedNCT00001643
- Genetic Analysis of Parkinson's DiseaseCompletedNCT00001640
- Diagnosis and Natural History Study of Patients With Neurological ConditionsCompletedNCT00001549
- Dextromethorphan for the Treatment of Parkinson's Disease and Similar Conditions of the Nervous SystemCompletedNCT00001365Phase 2
- Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258